These results, together with a previous report showing that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like habits in mice,2 assistance the concept of targeting ACKR3 as a unique solution to modulate the opioid method, which could open up new therapeutic avenues for opioid-associated Conditions.Increase healthier immune functionality